Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03839394 · ClinicalTrials.gov registry record · NA

Case Managers for CVD Risk Reduction in HIV Clinic

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03839394: Completed NA study, sponsored by Duke University.

NCT03839394 is a NA study that has completed, run by Duke University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03839394, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The purpose of the study is to assess the efficacy of a case manager/social worker administered, telephone-based educational curriculum in improving cardiovascular disease related outcomes among HIV-infected clinic patients.

Primary Outcome

Change of systolic blood pressure will be assessed as an absolute continuous variable, and as a proportion or persons who achieve \>5mmHg reduction in systolic blood pressure from baseline. Reported here is the change from baseline to 72 weeks.

Interventions

  • BEHAVIORAL Telephone
  • OTHER Educational pamphlets

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2020-10-12
Est. Completion 2023-09-14
Phase NA
Duke University

1,725 total trials

What the finished NCT03839394 record still lists

NCT03839394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Telephone is the first listed.

NCT03839394 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03839394 about?

NCT03839394 is a clinical study titled "Case Managers for CVD Risk Reduction in HIV Clinic". The purpose of the study is to assess the efficacy of a case manager/social worker administered, telephone-based educational curriculum in improving cardiovascular disease related outcomes among HIV-infected clinic patients.

What is the current status of trial NCT03839394?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-10-12. Estimated completion is 2023-09-14.

What interventions are being tested in trial NCT03839394?

The interventions under investigation include: Telephone (BEHAVIORAL), Educational pamphlets (OTHER).

Who is sponsoring clinical trial NCT03839394?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03839394's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03839394, the US trial registry maintained by the National Library of Medicine. NCT03839394 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.